USFDA approves injectable version of Bristol Myers Squibb’s Opdivo
The approval includes indications for renal cell carcinoma, melanoma, non-small cell lung cancer, head and neck squamous cell…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.